Literature DB >> 22164870

[Advances in research of dihydroartemisinin against parasitic diseases].

Hong-Jun Li1, Wei Wang, You-Sheng Liang.   

Abstract

Dihydroartemisinin, the main metabolite of artemisinin and two artemisinin derivatives, artemether and artesunate, is a broad-spectrum anti-parasitic drug. The present paper systematically reviews the advances in research of dihydroartemisinin against Plasmodium, Schistosoma, Pneumocystis, Toxoplasma, Trichomonas vaginalis, Leishmania, Giardia lamblia.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22164870

Source DB:  PubMed          Journal:  Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi        ISSN： 1005-6661


  4 in total

1.  Is there a reduced sensitivity of dihydroartemisinin against praziquantel-resistant Schistosoma japonicum?

Authors:  Wei Wang; Hong-Jun Li; Guo-Li Qu; Yun-Tian Xing; Zhen-Kun Yang; Jian-Rong Dai; You-Sheng Liang
Journal:  Parasitol Res       Date:  2013-10-22       Impact factor: 2.289

Review 2.  Artemisinin anti-malarial drugs in China.

Authors:  Zongru Guo
Journal:  Acta Pharm Sin B       Date:  2016-02-18       Impact factor: 11.413

Review 3.  Sesquiterpene Lactones from Artemisia Genus: Biological Activities and Methods of Analysis.

Authors:  Bianca Ivanescu; Anca Miron; Andreia Corciova
Journal:  J Anal Methods Chem       Date:  2015-10-01       Impact factor: 2.193

Review 4.  New uses for old drugs: the tale of artemisinin derivatives in the elimination of schistosomiasis japonica in China.

Authors:  Yi-Xin Liu; Wei Wu; Yue-Jin Liang; Zu-Liang Jie; Hui Wang; Wei Wang; Yi-Xin Huang
Journal:  Molecules       Date:  2014-09-19       Impact factor: 4.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.